PDGFRA and central nervous system cancer: Therefore, identifying the RTKs responsible for resistance to PDGFR inhibitors may synergistically enhance the anti-glioma efficacy.78 SHP-2 is a non-receptor protein tyrosine phosphatase encoded by the PTPN11 gene that is critical for PDGFRα-driven gliomagenesis.